Is the coverage of mass-drug-administration adequate for elimination of Bancroftian filariasis? An experience from West Bengal, India
Author(s) -
Dibakar Haldar,
Dhruba Mandal,
GautamNarayan Sarkar,
Sucharita Sarkar,
Abhik Sinha,
Debkumar Ghosh
Publication year - 2015
Publication title -
tropical parasitology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.418
H-Index - 11
eISSN - 2229-7758
pISSN - 2229-5070
DOI - 10.4103/2229-5070.149921
Subject(s) - mass drug administration , west bengal , bancroftian filariasis , filariasis , administration (probate law) , food and drug administration , medicine , drug , drug administration , lymphatic filariasis , wuchereria bancrofti , environmental health , socioeconomics , pharmacology , immunology , political science , economics , population , helminths , law
Bancroftian filariasis is the second most common mosquito-borne disease in India. Government of India adopted mass-drug-administration (MDA) since 2004 for its elimination by 2015 AD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom